Yingliang Wu Selected Research

Sepsis (Septicemia)

10/2021

AKT controls NLRP3 inflammasome activation by inducing DDX3X phosphorylation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yingliang Wu Research Topics

Disease

33	Neoplasms (Cancer) 11/2023 - 05/2010
15	Infections 01/2023 - 01/2011
9	Breast Neoplasms (Breast Cancer) 01/2023 - 03/2016
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023 - 06/2017
7	Virus Diseases (Viral Diseases) 11/2023 - 09/2015
7	COVID-19 01/2023 - 01/2020
6	Autoimmune Diseases (Autoimmune Disease) 11/2020 - 02/2011
5	Lung Neoplasms (Lung Cancer) 01/2023 - 10/2019
5	Inflammation (Inflammations) 10/2021 - 11/2014
4	Neoplasm Metastasis (Metastasis) 12/2023 - 04/2014
4	Channelopathies 11/2023 - 01/2011
4	Glioma (Gliomas) 01/2023 - 05/2010
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023 - 10/2013
3	Ataxia (Dyssynergia) 01/2021 - 10/2005
3	Bacterial Infections (Bacterial Infection) 08/2012 - 11/2008
2	Severe Fever with Thrombocytopenia Syndrome 01/2023 - 01/2020
2	Diabetic Foot 01/2022 - 08/2019
2	Lymphoma (Lymphomas) 01/2022 - 03/2018
2	Wounds and Injuries (Trauma) 01/2022 - 08/2019
2	Ulcer 01/2022 - 08/2019
2	Peritonitis 10/2021 - 01/2018
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 03/2021 - 11/2019
2	Epilepsy (Aura) 01/2021 - 01/2017
2	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2020 - 02/2015
2	Hypersensitivity (Allergy) 01/2019 - 03/2017
2	Adenocarcinoma 06/2017 - 01/2013
2	Fibrosarcoma 02/2015 - 08/2012
2	Cardiotoxicity 01/2014 - 06/2011
2	Edema (Dropsy) 12/2013 - 12/2005
1	Pain (Aches) 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 01/2023
1	Post-Acute COVID-19 Syndrome 05/2022
1	Sepsis (Septicemia) 10/2021
1	Tick Bites 01/2021
1	Pruritus (Itching) 01/2021
1	Rheumatoid Arthritis 11/2020

Drug/Important Bio-Agent (IBA)

23	Peptides (Polypeptides)IBA 11/2023 - 02/2007
12	Scorpion Venoms (Scorpion Venom)IBA 11/2023 - 01/2011
6	Phosphotransferases (Kinase)IBA 01/2023 - 03/2018
6	Proteins (Proteins, Gene)FDA Link 11/2022 - 08/2011
6	VaccinesIBA 01/2022 - 01/2019
5	Antiviral Agents (Antivirals)IBA 01/2022 - 07/2011
5	Phenol (Carbolic Acid)FDA Link 01/2022 - 03/2016
5	Anaplastic Lymphoma KinaseIBA 03/2021 - 03/2018
5	DefensinsIBA 01/2021 - 12/2017
4	Ion Channels (Ion Channel)IBA 01/2021 - 01/2011
4	fosbretabulin (combretastatin A4)IBA 12/2015 - 08/2012
3	CrizotinibIBA 12/2023 - 01/2018
3	PotassiumIBA 01/2023 - 01/2013
3	p38 Mitogen-Activated Protein KinasesIBA 01/2023 - 01/2020
3	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2022 - 03/2018
3	Tubulin ModulatorsIBA 01/2022 - 01/2017
3	Immune Checkpoint InhibitorsIBA 03/2021 - 08/2020
3	Potassium Channels (Potassium Channel)IBA 11/2020 - 02/2007
3	TubulinIBA 01/2020 - 02/2015
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 11/2011
2	Therapeutic UsesIBA 11/2023 - 01/2022
2	2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA 01/2023 - 11/2022
2	Chymotrypsin FDA Link 11/2022 - 04/2014
2	Paclitaxel (Taxol)FDA LinkGeneric 02/2022 - 08/2018
2	2- methoxy- 5- ((3,4,5- trimethosyphenyl)seleninyl)phenolIBA 01/2022 - 03/2016
2	Antimicrobial PeptidesIBA 01/2022 - 06/2016
2	B7-H1 AntigenIBA 03/2021 - 11/2020
2	Histamine (Histamine Dihydrochloride)FDA Link 01/2021 - 05/2008
2	CytokinesIBA 01/2021 - 08/2019
2	Indicators and Reagents (Reagents)IBA 11/2020 - 08/2019
2	VenomsIBA 01/2020 - 02/2014
2	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 01/2014
2	Glucose (Dextrose)FDA LinkGeneric 08/2019 - 01/2019
2	Interleukin-2 (IL2)IBA 01/2019 - 02/2015
2	InterferonsIBA 12/2018 - 01/2016
2	Chloride Channels (Chloride Channel)IBA 02/2016 - 05/2010
2	ChlorotoxinIBA 02/2016 - 11/2010
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2014 - 06/2011
2	4-methylcyclopentadecanoneIBA 01/2014 - 12/2013
2	Xylenes (Xylene)IBA 12/2013 - 12/2005
2	2- methoxy- 5- (2- (3,4,5- trimethoxyphenyl)thiophen- 3- yl)anilineIBA 01/2013 - 08/2012
1	Sirolimus (Rapamycin)FDA Link 12/2023
1	monodansylcadaverineIBA 12/2023
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2023
1	Acridine OrangeIBA 12/2023
1	TriazinesIBA 11/2022
1	ThiophenesIBA 11/2022
1	Angiotensin Receptor AntagonistsIBA 03/2022
1	ceritinibIBA 01/2022
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2022
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 11/2021
1	aluminum sulfate (alum)IBA 10/2021
1	CalciumIBA 01/2021
1	Salivary Proteins and PeptidesIBA 01/2021
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2021
1	capivasertibIBA 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Kv1.2 Potassium ChannelIBA 01/2021

Therapy/Procedure

14	Therapeutics 05/2022 - 05/2010
4	Immunotherapy 01/2023 - 08/2020
2	Drug Therapy (Chemotherapy) 07/2022 - 08/2020
2	Intravenous Injections 03/2016 - 08/2012
1	Critical Care (Surgical Intensive Care) 07/2022